Christian Berkhahn
Pediatrics · Louisville, KYNPI 1518005156
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $60,335 of the $84,518 with a category attached, or 71.4%. Supernus Pharmaceuticals, Inc. accounts for 73.4% of it on its own, with 21 other manufacturers making up the rest. Among pediatrics clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 406 payments — averaging $208.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$62K
- Genentech USA, Inc.$11K
- Ironshore Pharmaceuticals Inc.$6K
- Otsuka America Pharmaceutical, Inc.$4K
- Tris Pharma Inc$648
- Merck$240
- plus $907 from 16 others
What the payments were for
- Consulting fees$9,67011%
- Speaking & faculty fees$60,33571%
- Travel & lodging$8,33510%
- Food & beverage$6,1587%
- Education$200%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 272 | $62,037 |
| Genentech USA, Inc. | 20 | $10,803 |
| Ironshore Pharmaceuticals Inc. | 28 | $5,649 |
| Otsuka America Pharmaceutical, Inc. | 6 | $4,234 |
| Tris Pharma Inc | 27 | $648 |
| Merck | 9 | $240 |
| Sanofi Pasteur Inc. | 5 | $161 |
| Corium, LLC | 7 | $122 |
| Neos Therapeutics, LP | 6 | $115 |
| Collegium Pharmaceutical, Inc. | 5 | $110 |
| Cranial Technologies, Inc | 5 | $75 |
| Mckesson Medical-surgical, Inc. | 2 | $72 |
| Johnson & Johnson | 2 | $61 |
| Adlon Therapeutics L.p. | 3 | $42 |
| Pfizer | 2 | $35 |
| Ultragenyx Pharmaceutical Inc. | 1 | $22 |
| Verrica Pharmaceuticals Inc. | 1 | $21 |
| GSK | 1 | $17 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $15 |
| Sobi, Inc | 1 | $14 |
| Vertical Pharmaceuticals, LLC | 1 | $14 |
| Jazz Pharmaceuticals Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$58,859
- Xofluza$10,535
- Jornay PM 20mg capsules (Bottle of 100)$5,046
- Dyanavel XR$250
- Quillichew ER$250
- Quillivant$250
- JORNAY PM$125
How this compares
$84,518 in reported general payments places this provider in the 95th percentile of 777 pediatrics providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Eszopiclone | 11 | $766 |
Paid to pharmacies, not to this prescriber.
Other pediatrics in Louisville
- Maurice AllgeierLouisville$38K
- Patricia PurcellLouisville$27K
- Amber PendletonLouisville$10K
- Jeetendra SahLouisville$7K
- Klint SchwenkLouisville$6K
- Heather RushLouisville$5K
- Julia RichersonLouisville$4K
- Wendy DalyLouisville$4K
- Nicholas HinkebeinLouisville$4K
- Renee HeustisLouisville$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.